Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to evaluate the safety and plasma concentration changes of
quetiapine after multiple oral administration of FK949E (extended-release formulation of
quetiapine) in patients with major depressive disorder (MDD).